Header Logo

Connection

SUSAN HILSENBECK to Capecitabine

Back to Details
This is a "connection" page, showing publications SUSAN HILSENBECK has written about Capecitabine.
SUSAN HILSENBECK
Connection Strength
0.029
Capecitabine
  1. A phase II trial of capecitabine concomitantly with whole-brain radiotherapy followed by capecitabine and sunitinib for brain metastases from breast cancer. Oncologist. 2015 Jan; 20(1):13.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.